Clinical and Experimental Immunology: Highlights of 2023.

The article "Clinical and Experimental Immunology: Highlights of 2023" provides a summary of the research and achievements published in the journal throughout the year. It mentions the collaboration with the Federation of Clinical Immunology Societies (FOCIS) 2023 Annual Meeting and the compilation of research articles covering various fields of immunology. The article highlights specific studies on topics such as pembrolizumab-induced myasthenia gravis, lysophosphatidic acid treatment for neuropsychiatric systemic lupus erythematosus, and the impact of immunopeptide on pancreas homeostasis. It also mentions the introduction of new review series on unconventional T cells, inborn errors of immunity, and regulatory T cell enhancing approaches. The article concludes by expressing gratitude to the contributors and supporters of the journal. The document is a list of references to various articles on topics related to immunology, covering subjects such as leukocyte trafficking, unconventional T cells, innate lymphoid cells in transplantation, regulatory T-cell dysfunction, FOXP3+ regulators of immune responses, inborn errors of immunity, mutation types in immune disorders, regulatory T-cell enhancing approaches, and the role of B cells in granulomatosis with polyangiitis and COVID-19. [Extracted from the article]